Hot Features
Premium
Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Período:
Tipo de Línea:
| Volume | 0 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | Mínimo Máximo |
||||||
| Minimo del Dia | |||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Aridis Pharmaceuticals Inc | ARDS | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.289 | 19:00:00 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 0.289 | 0.289 |
| Operaciones | Volume Operado de la Acción | Volumen promedio | Rango 52 semanas |
|---|---|---|---|
| 0 | 0 | - | 0.16 - 0.5395 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| - | 0 | US$ 0.289 | USD |
Información Financiera Aridis Pharmaceuticals Inc ARDS
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 12.93M | 44.57M | - | 3.09M | -30.37M | -0.68 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Aridis Pharmaceuticals Inc ARDS
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 13/2/2024 | 19:02 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 16/1/2024 | 05:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 15/12/2023 | 15:15 | GlobeNewswire Inc. | Aridis Pharmaceuticals Announces Adjournment of Annual.. |
| 03/11/2023 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 03/11/2023 | 15:15 | GlobeNewswire Inc. | Aridis Pharmaceuticals Announces Third Quarter 2023.. |
| 03/11/2023 | 05:15 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 13/9/2023 | 20:47 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 07/9/2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 25/8/2023 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 04/8/2023 | 15:05 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 03/8/2023 | 15:15 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 02/8/2023 | 07:17 | GlobeNewswire Inc. | Aridis Pharmaceuticals Announces $2 Million Offering |
Histórico de Datos ARDS
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.228 | 0.5395 | 0.16 | 0.3588879 | 5,048,035 | 0.061 | 26.75% |
| 3 Years | 5.82 | 7.72 | 0.15 | 1.08 | 1,034,595 | -5.53 | -95.03% |
| 5 Years | 10.07 | 12.40 | 0.15 | 1.14 | 548,122 | -9.78 | -97.13% |
